Cite
HARVARD Citation
Hosono, Y. et al. (2023). Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1γ autoantibodies. Annals of the rheumatic diseases. 82 (2), pp. 246-252. [Online].